CLINICAL_TRIALS
trial_result
· 2026-03-11
Clinical Trial Update: PTH-independent Effects of Encaleret [Phase 2]
Summary
This update reports the completion and posting of Phase 2 results for Encaleret in post-surgical hypoparathyroidism, including observed PTH-independent effects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Post-Surgical Hypoparathyroidism | Phase 2 | Status: COMPLETED | Results posted: 2026-03-11